market-vectors

Gilead Could Goose Biotech ETFs

Some well-known biotechnology exchange traded funds could be stirred by Gilead Sciences (GILD) fourth-quarter earnings report released Tuesday after the close of U.S. markets.The California-based company posted net income of $3.49 billion, or $2.18 a share, compared with $791 million, or 47 cents a share, a year earlier as revenue more than doubled to $7.31 billion from $3.12 billion on […]

A-Shares ETFs Stand Tall as U.S. Stocks Wilt | ETF Trends

Current Affairs News:Women in ETFs Inspire the Next Generation of Leaders
S&P Consults Clients on Russian Stocks in its Indices
ETF Chart of the Day: High-Yield Anarchy
On a day that is shaping up to be dismal for U.S. stocks and less-than-cheery for most emerging markets exchange traded funds, ETFs holding Chinese A-shares are standing tall.The S&P 500 is off 1.6% while the […]